Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MabThera + MTX MRI Pilot in RA
NCT00502853Phase 4Completed
- Sponsor
- Roche
- Start
- Oct 2007
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of rituximab in rheumatoid arthritis (RA), sponsored by Roche. Started Oct 2007; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00502853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00502853.